| 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|
| Profit/loss | -120,8 k € | -94.8% | -62,0 k € | +83.7% | -379,7 k € | -148.0% | -153,1 k € | |
| Equity | -437,0 k € | -38.2% | -316,3 k € | -24.4% | -254,3 k € | -302.7% | 125,4 k € | |
| Gross margin | -43,0 k € | -318.6% | 19,7 k € | +107.0% | -280,6 k € | -217.9% | -88,3 k € | |
| Staff | — | — | — | — | ||||
| Unit no. | Name | Location |
|---|---|---|
| 2183994590 | Extense Pharma | Avenue Vendôme 1, 1380 Lasne |
Private company with limited liability · Wavre · incorporated on 17/12/2009
Company — Ouverture de faillite.
Private company with limited liability en perte sur le dernier exercice. Trésorerie en repli (-86.3 %).
Key indicators
7-day free trial, no credit card required.
Source: filing of 24/10/2022
Source: Belgian Official Gazette